Your EBGLYSS™ (lebrikizumab-lbkz) Starter Kit
To learn about potential savings, enroll with Lilly Support Services™ for EBGLYSS™ (lebrikizumab-lbkz).
What is the Starter Kit?
Your loved one and their doctor made the choice that EBGLYSS is right for them. This Starter Kit gives you details about EBGLYSS, explains what to expect, and provides savings opportunities for commercially insured patients.
Enrolling in Lilly Support Services, a customer support program, can be a way to help incorporate EBGLYSS into your loved one's life. By enrolling in this program, you and your loved one will receive services and resources to help understand what to expect when starting on EBGLYSS.
The program can help you and your loved one get started by connecting you with:
Savings* and Insurance Assistance
Injection Training
Sharps Disposal Container
One-on-one support with a Companion in Care™†
All of this will help you and your loved one to start in the right direction during the first days of using EBGLYSS.
For important administration and preparation instructions, talk to your doctor and refer to the Instructions for Use that came with your device.
*Governmental beneficiaries excluded. Terms and conditions apply. See enrollment form for details.
†Your Companion in Care™ provided by Lilly Support Services for EBGLYSS is not a medical professional. Your doctor is your source for medical advice.
INDICATION
EBGLYSS is a prescription medicine used to treat adults and children 12 years of age and older who weigh at least 88 pounds (40kg) with moderate-to-severe eczema (atopic dermatitis) that is not well controlled with prescription therapies used on the skin (topical), or who cannot use topical therapies. EBGLYSS can be used with or without topical corticosteroids.
It is not known if EBGLYSS is safe and effective in children less than 12 years of age or in children 12 years to less than 18 years of age who weigh less than 88 pounds (40 kg).
SELECT IMPORTANT SAFETY INFORMATION
Do not use EBGLYSS if you are allergic to lebrikizumab-lbkz or to any of the ingredients in EBGLYSS. See the Patient Information leaflet that comes with EBGLYSS for a complete list of ingredients.
How EBGLYSS works
EBGLYSS targets a main source of eczema inflammation that leads to dry, itchy, and irritated skin.
When you have eczema, your body produces too much of a specific protein called IL-13 that can lead to inflammation. EBGLYSS is specifically designed to target this protein and help reduce the inflammation that leads to dry, itchy, and irritated skin.
IL=interleukin
SELECT IMPORTANT SAFETY INFORMATION
Before using EBGLYSS, tell your healthcare provider about all your medical conditions, including if you:
Have a parasitic (helminth) infection.
Are scheduled to receive any vaccinations. You should not receive a “live vaccine” if you are treated with EBGLYSS.
Are pregnant or plan to become pregnant. It is not known if EBGLYSS will harm your unborn baby. If you become pregnant during treatment with EBGLYSS, you or your healthcare provider can call Eli Lilly and Company at 1-800-LillyRx (1-800-545-5979) to report the pregnancy.
Are breastfeeding or plan to breastfeed. It is not known if EBGLYSS passes into your breast milk.
Take prescription or over-the-counter medicines, vitamins, and herbal supplements.